October 26, 2006 FDA says it Screened Panelists for Conflicts of InterestFDA says it Screened Panelists for Conflicts of Interest Tue, 1 Mar 2005 Bloomberg News reports that Read More FDA says it Screened Panelists for Conflicts of Interest
October 26, 2006 NY Times Does it Again – Drug Advertisers Get Front Page Coverage to Boost SSRI MarketNY Times Does it Again – Drug Advertisers Get Front Page Coverage to Boost SSRI Market Wed, Read More NY Times Does it Again – Drug Advertisers Get Front Page Coverage to Boost SSRI Market
October 26, 2006 Lies & Broken Promises – Drug firm Websites Fail to Disclose Test DataLies & Broken Promises_Drug firm Websites Fail to Disclose Test Data Sun, 9 Jan 2005 One year Read More Lies & Broken Promises – Drug firm Websites Fail to Disclose Test Data
October 26, 2006 Conflicts of Interest policy – New York TimesConflicts of Interest policy – New York Times Sun, 28 Mar 2004 To: ‘Executive-editor@nytimes’; ‘gcollins@nytimes’; ‘arosenthal@nytimes’; ‘pboffey@nytimes’; Read More Conflicts of Interest policy – New York Times
October 26, 2006 UK: ADHD advice secretly paid for by drugs companiesUK: ADHD advice secretly paid for by drugs companies Sun, 09 Oct 2005 The phenomenal marketing of Read More UK: ADHD advice secretly paid for by drugs companies
October 26, 2006 How Did the Vioxx Debacle Happen? USA Today / LancetHow Did the Vioxx Debacle Happen? USA Today / Lancet Tue, 12 Oct 2004 Dr. Eric Topol Read More How Did the Vioxx Debacle Happen? USA Today / Lancet
October 26, 2006 ADHD drug Cylert withdrawn from market due to Liver ToxicityADHD drug – Cylert withdrawn from market due to Liver Toxicity, a Major Risk of Psychotropic Drugs Read More ADHD drug Cylert withdrawn from market due to Liver Toxicity
October 26, 2006 Cong. to act on GAO Finding: Families Give Up Kids to Get TreatmentCong. to act on GAO Finding: Families Give Up Kids to Get Treatment Tue, 29 Apr 2003 Read More Cong. to act on GAO Finding: Families Give Up Kids to Get Treatment
October 26, 2006 How Genentech, Novartis Stifled A Promising Drug – WSJHow Genentech, Novartis Stifled A Promising Drug – WSJ Tue, 05 Apr 2005 A front page story Read More How Genentech, Novartis Stifled A Promising Drug – WSJ
October 26, 2006 Cancer Trials: 60% to 70% of subjects are children – WSJJuly 26, 2002 Cancer Trials: 60% to 70% of subjects are children – Wall Street Journal The Read More Cancer Trials: 60% to 70% of subjects are children – WSJ
October 26, 2006 Infomail Archive, 2005Infomail 2005 News Stories on Human Research Protection and Commentary by Vera Hassner Sharav Subscribe to the Read More Infomail Archive, 2005
October 26, 2006 Penn Psychiatrist Files Whistleblower Lawsuit – Investigtion Confirms Medicare Chief LiedPhiladelphia Daily News Pharma Influence: Penn Psychiatrist Files Whistleblower Lawsuit – Investigtion Confirms Medicare Chief Lied to Read More Penn Psychiatrist Files Whistleblower Lawsuit – Investigtion Confirms Medicare Chief Lied
October 26, 2006 Broken Brains or Flawed Studies?Broken Brains or Flawed Studies? Thu, 24 Jul 2003 Broken Brains or Flawed Studies? A critical review Read More Broken Brains or Flawed Studies?
October 26, 2006 FDA Advisory Suicide Risk for Adults on Antidepressants / Advisory Committee Resistant to issue Warnings on ADHD drugsFDA Advisory Suicide Risk for Adults on Antidepressants / Advisory Committee Resistant to issue Warnings on ADHD Read More FDA Advisory Suicide Risk for Adults on Antidepressants / Advisory Committee Resistant to issue Warnings on ADHD drugs